Enovis ROE 2010-2024 | ENOV

Current and historical return on equity (ROE) values for Enovis (ENOV) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Enovis ROE - Return on Equity Historical Data
Date TTM Net Income Shareholder's Equity Return on Equity
2024-12-31 $-0.83B $2.56B -26.44%
2024-09-30 $-0.12B $3.33B -3.59%
2024-06-30 $-0.09B $3.29B -2.70%
2024-03-31 $-0.08B $3.31B -2.41%
2023-12-31 $-0.03B $3.42B -0.96%
2023-09-30 $-0.08B $3.44B -2.18%
2023-06-30 $-0.14B $3.45B -4.04%
2023-03-31 $-0.05B $3.45B -1.51%
2022-12-31 $-0.01B $3.45B -0.37%
2022-09-30 $0.02B $3.41B 0.57%
2022-06-30 $0.12B $3.49B 2.66%
2022-03-31 $0.07B $4.64B 1.49%
2021-12-31 $0.07B $4.66B 1.61%
2021-09-30 $0.11B $4.63B 2.54%
2021-06-30 $0.09B $4.35B 2.40%
2021-03-31 $0.06B $4.29B 1.55%
2020-12-31 $0.04B $3.59B 1.22%
2020-09-30 $-0.01B $3.46B -0.23%
2020-06-30 $-0.01B $3.40B -0.33%
2020-03-31 $-0.47B $3.34B -14.28%
2019-12-31 $-0.53B $3.49B -15.51%
2019-09-30 $-0.47B $3.13B -13.67%
2019-06-30 $-0.44B $3.26B -12.73%
2019-03-31 $0.06B $3.74B 1.77%
2018-12-31 $0.14B $3.48B 3.91%
2018-09-30 $0.11B $3.48B 2.93%
2018-06-30 $0.12B $3.54B 3.34%
2018-03-31 $0.14B $3.84B 3.79%
2017-12-31 $0.15B $3.73B 4.37%
2017-09-30 $0.18B $3.51B 5.34%
2017-06-30 $0.16B $3.37B 4.92%
2017-03-31 $0.15B $3.21B 4.59%
2016-12-31 $0.13B $3.09B 4.08%
2016-09-30 $0.14B $3.17B 4.21%
2016-06-30 $0.13B $3.16B 3.86%
2016-03-31 $0.14B $3.24B 4.17%
2015-12-31 $0.17B $3.26B 5.05%
2015-09-30 $0.20B $3.30B 6.09%
2015-06-30 $0.26B $3.43B 7.61%
2015-03-31 $0.40B $3.25B 11.52%
2014-12-31 $0.37B $3.35B 10.62%
2014-09-30 $0.33B $3.54B 9.76%
2014-06-30 $0.30B $3.65B 9.78%
2014-03-31 $0.16B $3.40B 5.87%
2013-12-31 $0.16B $2.74B 6.46%
2013-09-30 $0.14B $2.57B 6.00%
2013-06-30 $0.09B $2.40B 4.18%
2013-03-31 $0.05B $2.06B 2.16%
2012-12-31 $-0.08B $2.16B -3.83%
2012-09-30 $-0.11B $2.18B -6.81%
2012-06-30 $-0.11B $2.10B -9.58%
2012-03-31 $-0.11B $2.22B -15.27%
2011-12-31 $0.01B $0.19B 2.16%
2011-09-30 $0.03B $0.25B 12.59%
2011-06-30 $0.03B $0.25B 13.70%
2011-03-31 $0.02B $0.24B 11.10%
2010-12-31 $0.02B $0.22B 8.29%
2010-09-30 $0.02B $0.23B 7.31%
2010-06-30 $0.02B $0.19B 7.58%
2010-03-31 $0.02B $0.19B 8.61%
2009-12-31 $0.02B $0.22B 12.53%
Sector Industry Market Cap Revenue
Medical Medical Information Systems $2.060B $2.108B
Enovis Corporation is a medical technology company. Its range of products, services and integrated technologies fuel active lifestyles in orthopedics and beyond. Enovis Corporation, formerly known as Colfax Corporation, is based in Wilmington, DE.
Stock Name Country Market Cap PE Ratio
Veeva Systems (VEEV) United States $39.499B 54.56
Hims & Hers Health (HIMS) United States $14.471B 150.35
Tempus AI (TEM) United States $11.278B 0.00
Inspire Medical Systems (INSP) United States $4.503B 70.35
IRhythm Technologies (IRTC) United States $4.501B 0.00
Privia Health (PRVA) United States $3.050B 208.50
Clover Health Investments (CLOV) United States $1.807B 0.00
Schrodinger (SDGR) United States $1.722B 0.00
Phreesia (PHR) United States $1.510B 0.00
Omnicell (OMCL) United States $1.310B 23.11
Azenta (AZTA) United States $1.258B 58.45
10x Genomics (TXG) United States $1.148B 0.00
Fulgent Genetics (FLGT) United States $0.620B 0.00
Butterfly Network (BFLY) United States $0.581B 0.00
Talkspace (TALK) United States $0.499B 149.00
Veradigm (MDRX) United States $0.455B 0.00
Claritev (CTEV) United States $0.450B 0.00
Standard BioTools (LAB) United States $0.410B 0.00
TruBridge (TBRG) United States $0.376B 834.67
Health Catalyst (HCAT) United States $0.283B 0.00
Nyxoah SA (NYXH) Belgium $0.214B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.197B 0.00
EUDA Health Holdings (EUDA) Singapore $0.142B 0.00
Pulmonx (LUNG) United States $0.138B 0.00
American Well (AMWL) United States $0.116B 0.00
MDxHealth SA (MDXH) Belgium $0.099B 0.00
CareCloud (CCLD) United States $0.089B 3.39
Outset Medical (OM) United States $0.070B 0.00
111 (YI) China $0.067B 0.00
Retrieve Medical Holdings (RMHI) United States $0.059B 0.00
P3 Health Partners (PIII) United States $0.057B 0.00
HeartBeam (BEAT) United States $0.052B 0.00
Zepp Health (ZEPP) Netherlands $0.042B 0.00
Zhongchao (ZCMD) China $0.032B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.023B 0.00
Bullfrog AI Holdings (BFRG) United States $0.016B 0.00
MSP Recovery (MSPR) United States $0.013B 0.00
Precipio (PRPO) United States $0.012B 0.00
Strata Skin Sciences (SSKN) United States $0.011B 0.00
Predictive Oncology (POAI) United States $0.010B 0.00
Streamline Health Solutions (STRM) United States $0.010B 0.00
Movano (MOVE) United States $0.007B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.004B 0.00
Tivic Health Systems (TIVC) United States $0.004B 0.00
HeartSciences (HSCS) United States $0.004B 0.00
Healthcare Triangle (HCTI) United States $0.000B 0.00
Future Health ESG (FHLT) United States $0.000B 0.00